World Mental health Day 2021

For Lundbeck, ‘Mental health in an unequal world’ means addressing the inequalities on the global treatment gap and investment shortages in mental health.

Check out the feature

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.

About Us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Our Science

LATEST NEWS

14 October, 2021 Press Release
Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio
04 October, 2021 Feature
World Mental Health Day 2021
01 October, 2021 Corporate Release
U.S. court issues decision in Trintellix patent litigation upholding active ingredient patent

See All News

Come join us in making a difference to patients worldwide.

Job Opportunities

Explore the latest financial developments at Lundbeck.

Investors

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease.

Patients

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

jason F. houston on working at Lundbeck

Advocacy Makes the Difference

See All Stories

Lundbeck at a glance

100

countries where our products are sold

5,600

employees supporting our purpose

1915

year Lundbeck was founded

No Health Without Mental Health

A Strange Dream

A Small Caterpillar Taking Cover Under a Leaf

So Perfect, So Vulnerable